Disc Medicine, Inc. (IRON)
67.52
-1.13
(-1.65%)
USD |
NASDAQ |
May 07, 16:00
67.52
0.00 (0.00%)
After-Hours: 20:00
Disc Medicine SG&A Expense (TTM) : 53.20M for March 31, 2026
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Amylyx Pharmaceuticals, Inc. | 62.89M |
| Eli Lilly & Co. | 11.56B |
| Masimo Corp. | 386.60M |
| Cytokinetics, Inc. | 226.90M |
| Regeneron Pharmaceuticals, Inc. | 2.715B |